Երկիր: Իռլանդիա
Լեզու: անգլերեն
Աղբյուրը: HPRA (Health Products Regulatory Authority)
Magnesium
Rowa Pharmaceuticals Limited
A12CC05
Magnesium
5 millimole(s)
Granules for oral solution
Product not subject to medical prescription
magnesium aspartate
Marketed
1997-02-25
Package leaflet: Information for the user _MAGNESIUM VERLA _ _5MMOL GRANULES FOR ORAL SOLUTION_ MAGNESIUM (AS MAGNESIUM ASPARTATE DIHYDRATE) __________________________________________________________________________________ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET: 1. What Magnesium Verla is and what it is used for 2. What you need to know before you take Magnesium Verla 3. How to take Magnesium Verla 4. Possible side effects 5. How to store Magnesium Verla 6. Contents of the pack and other information 1. WHAT MAGNESIUM VERLA IS AND WHAT IT IS USED FOR The name of this product is Magnesium Verla 5 mmol granules for oral solution. This medicine is used as a dietary supplement for individuals who are deficient in magnesium. This may be a result of an insufficient intake of the mineral in your diet or your body is not absorbing magnesium adequately. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MAGNESIUM VERLA DO NOT TAKE MAGNESIUM VERLA: • if you are allergic to magnesium aspartate dihydrate or any of the other ingredients of this medicine (listed in Section 6) • if you are dehydrated • if you have severe kidney problems • if you have a tendency to develop kidney stones during kidney infection • if you suffer from a condition where your kidneys are failing to produce urine (anuria) or are producing an abnormally small amount of urine (oliguria). WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before taking Magnesium Verla • if you a Կարդացեք ամբողջական փաստաթուղթը
Health Products Regulatory Authority 13 January 2021 CRN009Z3Z Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Magnesium Verla 5 mmol granules for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 g sachet of granules contains magnesium aspartate dihydrate equivalent to 121.56 mg (5 mmol) of magnesium. Excipient(s) with known effect: Sucrose 2.84 g per sachet Lactose 2.3 mg per sachet For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Granules for oral solution Yellow-tinged, free-flowing granules for solution with a slight odour and taste of tangerine that reduces during storage. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the correction of magnesium deficiency. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults and children over 10 years of age: The contents of one sachet (5 g) in-water, tea or fruit juice 1-3 times daily. Children 2 to 10 years: The contents of one sachet (5 g) in water, tea or fruit juice daily. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Use in patients with oliguria, anuria, severe renal insufficiency, dehydration and diathesis for secondary renal calculi. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE The product should be administered with caution in cases of impaired renal function. Consideration should be given to monitoring electrolytes. Magnesium Verla contains sucrose, lactose and sodium 1. The sugar content requires caution when used in diabetics. 2. This medicinal product contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. 3. This medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine. 4. This medicinal product contains less than 1 mmol sodium (23 mg) per sachet, that is to say ess Կարդացեք ամբողջական փաստաթուղթը